Patrick Pauwels

Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression.

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.

Complex genetic alterations in gastrointestinal stromal tumors with autonomic nerve differentiation.

Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma.

ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.

Uterine gastrointestinal stromal tumour (GIST).

Metastasized angiosarcoma of the spleen in a 2-year-old girl.

Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

Inflammatory myofibroblastic tumor with ALK/TPM3 fusion presenting as ileocolic intussusception: an unusual presentation of an unusual neoplasm.

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.

Differences in imiquimod treatment outcome in two patients with bowenoid papulosis containing either episomal or integrated human papillomavirus 16.

One-stage penectomy and phalloplasty for epithelioid sarcoma of the penis in an adolescent.

Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.

Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis.

Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.

One-stage penectomy and phalloplasty for epithelioid sarcoma of the penis in an adolescent: part 2.

Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.

Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry.

Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion.

Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front.

Re: Plexiform angiomyxoid myofibroblastic tumor of the stomach.

Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.

The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment.

Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.

Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.

Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis.

Prognostic role of vasculogenic mimicry in colorectal cancer.

Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.

Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.

Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.

Array-based DNA methylation profiling for breast cancer subtype discrimination.

Postextubation obstructive pseudomembranes: a case series and review of a rare complication after endotracheal intubation.

Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice?

The presence of Y chromosomal deoxyribonucleic acid in the female vaginal swab: possible implications for human papillomavirus testing.

Recognition of cellular implants by the brain's innate immune system.

MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?

Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations.

Labeling of Luciferase/eGFP-expressing bone marrow-derived stromal cells with fluorescent micron-sized iron oxide particles improves quantitative and qualitative multimodal imaging of cellular grafts in vivo.

EGFR in melanoma: clinical significance and potential therapeutic target.

Current challenges for the advancement of neural stem cell biology and transplantation research.

Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.

Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.

(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.

Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE material.

Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.

Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model.

Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.

Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.

Cell type-associated differences in migration, survival, and immunogenicity following grafting in CNS tissue.

Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.

An immunohistochemical analysis of Rab27B distribution in fetal and adult tissue.

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations.

Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain.

The interaction between ER and NFκB in resistance to endocrine therapy.

Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma.

Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays.

Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression.

Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples.

Smooth muscle cell transplantation improves bladder contractile function in streptozocin-induced diabetic rats.

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

Sarcomatous degeneration in fibrous dysplasia of the rib cage.

Krüppel-like factors in cancer progression: three fingers on the steering wheel.

Detection of ALK expression in non-small-cell lung cancer with ALK gene rearrangements--comparison of multiple immunohistochemical methods.

Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.

Looking for a new panacea in ALK-rearranged NSCLC: may be Ceritinib?

The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins.

The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization.

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.

Liquid biopsies in lung cancer: the new ambrosia of researchers.

Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer.

The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?

Improvement in lung cancer outcomes with targeted therapies: an update for family physicians.

Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): a feasibility study.

Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer.

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.

Onartuzumab in lung cancer: the fall of Icarus?

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis.

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer.

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer.

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.

Proteomics in cancer research: Are we ready for clinical practice?

Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2.

Targeting immune checkpoints: New opportunity for mesothelioma treatment?

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect.

TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value.

Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model.

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.

Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues.

APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.

Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using (18)F-FDG PET/CT for Monitoring Treatment Response.